Vanessa P M van Empel1, Joy Lee2, Trevor J Williams2, David M Kaye3. 1. Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Heart Center, Alfred Hospital, Melbourne, Australia. Electronic address: vpmvanempel@hotmail.com. 2. Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne, Australia. 3. Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Heart Center, Alfred Hospital, Melbourne, Australia; Department of Medicine, Monash University, Australia.
Abstract
BACKGROUND: Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arterial hypertension (iPAH) patients, with the potential to influence cardiac performance, pulmonary artery pressures and the pulmonary vascular response to hypoxia. METHODS: Iron status was evaluated in 29 iPAH patients, and was related to haemodynamic, echocardiographic and exercise parameters. RESULTS: Iron deficiency was present in 44.8% of all iPAH patients, although anaemia was only present in 13.8%. Iron-deficient patients had similar exercise capacity (6MWD: 446±141 m), compared to iron-sufficient patients (421±193 m), however 46.2% of iron deficient patients had NYHA FC 3 or higher, compared to 12.5% in non-iron deficient group. Additionally iron-deficient patients showed increased mean pulmonary arterial pressure (63.3±12.2 mmHg; iron deficient vs. 38.8±16.7 mmHg; non-iron deficient) and reduced cardiac index (1.3±0.2 L/min/m(2); iron deficient vs. 2.5±0.4 L/min/m(2); non-iron deficient). CONCLUSIONS: Iron deficiency is highly prevalent in iPAH, and the extent of iron deficiency is related to haemodynamics and NYHA functional class. While the exact mechanism of iron deficiency is unknown, our study suggests that treatment of iron deficiency should be considered in iPAH patients.
BACKGROUND:Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arterial hypertension (iPAH) patients, with the potential to influence cardiac performance, pulmonary artery pressures and the pulmonary vascular response to hypoxia. METHODS:Iron status was evaluated in 29 iPAH patients, and was related to haemodynamic, echocardiographic and exercise parameters. RESULTS:Iron deficiency was present in 44.8% of all iPAH patients, although anaemia was only present in 13.8%. Iron-deficientpatients had similar exercise capacity (6MWD: 446±141 m), compared to iron-sufficient patients (421±193 m), however 46.2% of iron deficient patients had NYHA FC 3 or higher, compared to 12.5% in non-iron deficient group. Additionally iron-deficientpatients showed increased mean pulmonary arterial pressure (63.3±12.2 mmHg; iron deficient vs. 38.8±16.7 mmHg; non-iron deficient) and reduced cardiac index (1.3±0.2 L/min/m(2); iron deficient vs. 2.5±0.4 L/min/m(2); non-iron deficient). CONCLUSIONS:Iron deficiency is highly prevalent in iPAH, and the extent of iron deficiency is related to haemodynamics and NYHA functional class. While the exact mechanism of iron deficiency is unknown, our study suggests that treatment of iron deficiency should be considered in iPAH patients.
Authors: Stephan von Haehling; Ewa A Jankowska; Dirk J van Veldhuisen; Piotr Ponikowski; Stefan D Anker Journal: Nat Rev Cardiol Date: 2015-07-21 Impact factor: 32.419
Authors: Gerrina Ruiter; Emmy Manders; Chris M Happé; Ingrid Schalij; Herman Groepenhoff; Luke S Howard; Martin R Wilkins; Harm J Bogaard; Nico Westerhof; Willem J van der Laarse; Frances S de Man; Anton Vonk-Noordegraaf Journal: Pulm Circ Date: 2015-09 Impact factor: 3.017
Authors: Jasmine Tatah; Jennifer L Keen; Sasha Z Prisco; Marc Pritzker; Thenappan Thenappan; Kurt W Prins Journal: Chest Date: 2021-08-02 Impact factor: 9.410
Authors: Ioan Tilea; Dorina Nastasia Petra; Razvan Constantin Serban; Manuela Rozalia Gabor; Mariana Cornelia Tilinca; Leonard Azamfirei; Andreea Varga Journal: Int J Gen Med Date: 2021-07-12